SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001962918-23-000044
Filing Date
2023-11-09
Accepted
2023-11-09 16:12:11
Documents
84
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q slrn-20230930.htm   iXBRL 10-Q 1733889
2 EX-31.1 slrn-20230930x10qexx311.htm EX-31.1 9503
3 EX-31.2 slrn-20230930x10qexx312.htm EX-31.2 9510
4 EX-32 slrn-20230930x10qexx321.htm EX-32 6137
  Complete submission text file 0001962918-23-000044.txt   8692462

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20230930.xsd EX-101.SCH 66585
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT slrn-20230930_cal.xml EX-101.CAL 75169
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT slrn-20230930_def.xml EX-101.DEF 320132
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20230930_lab.xml EX-101.LAB 821859
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20230930_pre.xml EX-101.PRE 571459
78 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20230930_htm.xml XML 1037209
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41696 | Film No.: 231392534
SIC: 2834 Pharmaceutical Preparations